Gu F, Wu E, Yan X, Huang W, et al. AHSA1 as a prognostic biomarker and potential immunotherapeutic target in HNSCC: integrative bulk RNA-seq, scRNA-seq analyses and experimental validation. BMC Cancer 2025;25:1560.
PMID: 41088097